A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause in patiENts with Atrial fibrillation/atrial flutter
Literaturstellen
J.Cardiovasc.Electrophysiol. 2008,19,69
N.Engl.J.Med. 2009,360,668; 2480; 2487
Rev.Esp.Cardiol. 2009,62,479
Circulation 2009,120,1174
Eur.Heart J. 2010,31,1717; 2011,32Suppl.618 Abstract